Physician profile
Christopher Behr
NPI 1962792473
$7,314.38
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $18.88 · 2021: $15.98 · 2022: $516 · 2023: $205 · 2024: $6,558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $791 · Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $791.09 |
| Food and Beverage | $472.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,972.63 | 2022-2024 | |
| Kerecis Limited | $67.46 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Davol INC. | $53.94 | 2022 | |
| Innovation Technologies INC | $53.31 | 2023 | Irrisept |
| W. L. Gore & Associates, INC. | $43.72 | 2021-2024 | Gore Synecor Biomaterial |
| Ethicon US, LLC | $41.14 | 2020-2023 | Monocryl |
| Baxter Healthcare | $29.89 | 2022 | |
| Integra Lifesciences Corporation | $27.70 | 2023 | Integra, Surgimend, Omnigraft |
| Haemonetics Corporation | $24.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Behr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.